AI Summary
Well-known law firm Wohl & Fruchter LLP is examining the fairness of Huntsman’s proposed merger with Olin, which would pay 0.5476 Olin shares per Huntsman. Huntsman stock dropped roughly 18% on the news, implying about $13.85 per HUN vs a $15.89 close on June 15. Analysts’ targets remain $15–$16, signaling downside risk if terms aren’t improved.
Sentiment Rationale
The merger fairness inquiry plus an 18% intraday drop and an implied price of ~$13.85 (well below prior close) signal downside risk absent favorable deal developments; historical precedent shows legal probes can stall mergers and depress stock until terms are clarified.
Trading Thesis
Near-term bearish risk for HUN as legal review could delay or alter the deal; monitor for renegotiation or litigation outcomes over weeks.
Market-Moving
- Huntsman shares down ~18% intraday on merger news (11:45 ET).
- Implied HUN value ~ $13.85 vs June 15 close of $15.89.
- Olin close on June 15 was $25.30; exchange ratio drives implied price.
- Legal investigation adds potential for delay or renegotiation.
Key Facts
- Wohl & Fruchter LLP investigates Huntsman-Olin merger fairness; exchange ratio 0.5476 OLN per HUN.
- Huntsman stock down ~18% on merger news; implied value about $13.85 per HUN.
- Analysts’ targets around $15–$16; downside risk if terms don’t improve.
- Investigation could delay or alter the deal, affecting Huntsman shareholders.
Companies Mentioned
- Huntsman Corporation (HUN): Subject of the merger; fairness inquiry could influence deal timing and shareholder value.
- Olin Corporation (OLN): Counterparty to the merger; exchange ratio directly affects implied Huntsman value.
- Citigroup (C): Analyst target $16; supports upside if terms are adjusted favorably.
- Morgan Stanley (MS): Analyst target $15; marks valuation pressure against implied price.
- Deutsche Bank (DB): Analyst target $15; reinforces near-term valuation risk for HUN.
- Goldman Sachs (GS): Analyst target $15; indicates market pricing around merger terms.
Legal
Category: Legal. The piece centers on a law-firm investigation into a major M&A deal, highlighting potential delays, governance questions, and valuation risk that could affect Huntsman in the near term.